Cartilage oligomeric matrix expression in patients with chronic hepatitis C <b>[Abstract in English]</b>
Abstract
Purpose: Chronic hepatitis C is an insidiously progressive disease, in witch repeated assessment of liver histology is required. Various serum markers have now been introduced. Cartilage oligomeric matrix protein (COMP) is the fifth member of the trombospondin family of extra cellular calcium-binding proteins. It was initially isolated and characterized in cartilage tissue. One study investigated the expression of COMP in normal liver, liver cirrhosis and hepatocellular carcinoma tissues. Our present aim was to asses the serum COMP in patients with chronic hepatitis C.Methods and results: Serum levels of COMP were measured in 10 patients with chronic hepatitis C (cases) and 100 healthy patients (controls). The difference between two groups was not statistical significant and not related to clinical stage of liver fibrosis, virus genotypes, platelets or transaminases alterations.
Conclusion: COMP was absent or rarely expressed in liver cirrhosis tissues. Others serum fibrotic markers have now been studied.
KEY WORDS: BIOLOGICAL MARKERS; THROMBOSPONDINS; HEPATITIS C, CHRONIC; LIVER CIRRHOSIS.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.